INC

INC Research to acquire Kendle in all-cash deal to help compete for strategic deals with big pharma

Monday, May 9, 2011 09:38 AM

After months of rumors about Kendle International being on the block, CRO INC Research late last week announced it would buy the mid-tier publicly held CRO in an all-cash transaction. If the deal goes through, Kendle will be taken private.

More... »

INC Research to acquire Kendle International

Thursday, May 5, 2011 01:24 PM

INC Research, a therapeutically focused global CRO privately held by Avista Capital Partners and Ontario Teachers' Pension Plan, and CRO Kendle International, have jointly announced a definitive merger agreement. Raleigh, N.C.-based INC Research will acquire Kendle in an all-cash transaction with a total equity value of approximately $232 million.

More... »

Nautic purchase of Omnicare Clinical Research part of recent acquisition trend of mid-sized CROs

Thursday, May 5, 2011 01:22 PM

Omnicare Clinical Research, which had been part of publicly traded long-term care pharmacy company Omnicare Inc. since the late 1990s, was acquired by private equity firm Nautic Partners last week, making it one of several mid-sized CROs to be acquired in the last year.

More... »

Vince & Associates Clinical Research expands

Thursday, April 21, 2011 12:33 PM

Kansas-based Vince & Associates Clinical Research, a provider of phase I-IV clinical trial services to the global biopharmaceutical industry, has opened a 90-bed clinical pharmacology research unit.

More... »

Patrick Melvin joins oncology leadership team at INC Research

Tuesday, March 1, 2011 08:00 AM

CRO INC Research has named Patrick Melvin executive director, Oncology. He will be using his hematology/oncology trial experience for phase I first-in-man studies through pivotal global phase IV programs.

More... »

RPS to Raise $100 Million in IPO

Wednesday, June 23, 2010 08:15 AM

ReSearch Pharmaceutical Services (RPS) plans an initial public offering in the U.S. on the Nasdaq exchange. The Fort Washington, Pa.-based contract research organization (CRO ) seeks to raise $100 million from the IPO.

More... »

Site-less, PI-less Trials?

Thursday, June 10, 2010 08:58 AM

Quincy Bioscience just may be on to something. The Madison, Wis.-based maker of the jellyfish-based supplement Prevagen has just launched a portal that allows most interactions with its study subjects to take place exclusively online.

More... »

INC Research Provides ePRO Services Through Invivodata Partnership

Friday, March 12, 2010 06:34 AM

Raleigh, N.C.-based CRO  INC Research added electronic patient reported outcomes (ePRO) services to its offerings through a partnership with ePRO provider invivodata. Prior to the formation of the strategic partnership, the two companies collaborated on multiple international clinical trials.

More... »

INC Research Launches Alliance Partnerships Program

Wednesday, February 24, 2010 06:45 AM

Raleigh, N.C.-based CRO INC Research launched an alliance partnerships program to create and manage strategic alliances with pharmaceutical and biotech customers. The company said it hopes to create relationships with customers based on joint strategic objectives rather than service agreements.

More... »

Dedicated Phase I Appoints New CMO

Friday, June 26, 2009 10:54 AM

Dedicated Phase I in Phoenix, Ariz., named a new chief medical officer to head its 80-bed phase I clinical research facility. Clark Springgate, M.D., Ph.D., brings more than 25 years' experience to the organization, having directed and participated in more than 256 clinical trials, including first-in-man and first-in-therapeutic-class studies.

More... »